Drugs / Refresh Optive
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03380624 | Mar 2017 → Jun 2018 | dry eye syndrome | Ohio State University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Refresh Optive | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03380624 ↗ |
| Modality | Other / unclassified | “two US Monograph lubricant eyedrop formulations” NCT03380624 ↗ |
| Route | Other | “one drop of Refresh Optive in each eye” NCT03380624 ↗ |